Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejection

Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejection

US Patent 10086070 · Granted Oct 2, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant alpha-1-antitrypsin compositions and use thereof2022
IL-1beta propeptide and IL-1Ra chimera and methods of using the same2018
Compositions and methods related to graft versus host disease and treatments the2018
Compositions and methods for modulating cardiac conditions2016
Compositions, methods and uses of alpha 1-antitrypsin for early intervention in 2016
Compositions and methods of use for alpha-1 antitrypsin having no significant se2014